FDA Recall Terminated Historical recordClass II
Nicardipine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
Data Explorer
Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.
Recall totals
All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.
37,139
Total recall recordsAll FDA and USDA recalls in Public Health Trace9,799
Class I recallsReasonable probability of serious health consequences24,349
Class II recallsTemporary or medically reversible health consequences2,891
Class III recallsNot likely to cause adverse health consequencesQuick insights
A snapshot of the most notable patterns across all recorded FDA and USDA recalls.
Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap.
53 recalls
Most common hazardLack of Assurance of Sterility
2,072 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/deanos-pasta-issue-allergy-alert-undeclared-lobster-pear-and-pecorino-triangoli-ravioliPublished September 24, 2026
Download matching recalls as CSV
CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.
Filters
Metric
View
A chart of recalls grouped by month.
Download CSVSummary (Year to date)
- 1,527 recalls have been announced year to date.
- Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
- The highest complete period was Jun 2026 (297).
- Sep 2026 is incomplete and not included in the figures above.
- Complete data
- Incomplete
A bar chart of the total number of recalls in this dataset by recall class.
| Class | Recalls |
|---|---|
| Class II | 24,349 |
| Class I | 9,799 |
| Class III | 2,891 |
| Not Yet Classified | 1 |
| Class | Recalls |
|---|---|
| Class II | 24,349 |
| Class I | 9,799 |
| Class III | 2,891 |
| Not Yet Classified | 1 |
FDA Recall Terminated Historical recordClass II
Dexamethasone Sodium Phosphate added to 5% Dextrose in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Rocuronium Bromide in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Methadone HCl Injection in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Meperidine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Esmolol HCl in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Dexamethasone Sodium Phosphate added to 0.9% Sodium Chloride in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Vecuronium Bromide in Sterile Water for Injection in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Neostigmine Methylsulfate Injection in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Labetalol HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Nicardipine HCl in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Ropivacaine HCl Injection in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
HYDROmorphone HCl in 5% Dextrose in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Atropine Sulfate Injection in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Lidocaine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Glycopyrrolate in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Ropivacaine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Ketamine HCl Injection in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Ephedrine Sulfate Injection in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Fentanyl Citrate Injection in all strengths, all doses, and all packaging.
- Reason
- Lack of sterility assurance.
- Published
- February 28, 2018
- Distribution
- Nationwide
Data last updated:
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.
